The authors analyzed data from over 50,000 health records and claims for insured adults diagnosed with alcohol use disorder at a large California health system during two periods: March to December 2019, before the onset of the COVID-19 pandemic, and March to December 2020, when care began to transition to telehealth due to the pandemic.
Utilization of alcohol treatment increased during the first nine months of the COVID-19 pandemic for all racial/ethnic and socioeconomic groups. The proportion of people initiating treatment after diagnosis of an alcohol problem rose from 24% before the pandemic to 32% after the onset of the pandemic. The rates of people engaging in two or more treatment sessions after initiating treatment also rose—from 34% before the pandemic to 41% after the pandemic began.
Telehealth appeared to provide particular benefits to specific age groups. Adults aged 18 to 34 years old without medical and psychiatric conditions had the highest increases in treatment initiation, by telehealth in particular. And adults aged 35-49 who initiated treatment via telehealth remained engaged in treatment during the pandemic at higher rates.
The transition to telehealth did not appear to worsen disparities among racial and ethnic groups. Further, people living in socioeconomically disadvantaged neighborhoods had some of the greatest increases in telehealth treatment initiation during the pandemic.
The study did not examine telehealth treatment effectiveness or the reasons for increased treatment utilization, some of which may be due to other circumstances presented by the pandemic. Additionally, the study was limited to people who remained insured by the plan throughout the study. The authors recommend further research to understand whether telehealth removed barriers to treatment and to address persistent disparities in alcohol treatment utilization by age, race, and ethnicity and for people with psychiatric and medical conditions.
COVID-19 pandemic-related changes in utilization of telehealth and treatment overall for alcohol use problems. V. Palzes, F. Chi, V. Metz, C. Campbell, C. Corriveau, S. Sterling. (pp. xxx)
ACER-22-5361.R1